SimBinder-IF: Structure-Aware Antibody Affinity Optimization via Efficient Preference Learning

Clicks: 4
ID: 322260
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #224 of 825 articles by views in BMC Bioinformatics

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 825 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Motivation Antibody therapeutic efficacy depends on high-affinity target engagement, yet laboratory affinity maturation is slow and costly. Most protein language models (PLMs) lack explicit training for high affinity, and current preference optimization methods introduce computational overhead without clear affinity improvements. Therefore, structure-aware and parameter-efficient approaches for antibody affinity optimization are urgently needed. Results We propose SimBinder-IF, a structure-aware antibody optimization model trained by freezing the Evolutionary Scale Modeling inverse folding (ESM-IF) structure encoder and fine-tuning only its decoder via Simple Preference Optimization (SimPO) to prefer stronger binders. In generalization tests across seven held-out complexes (93 477 mutants), SimBinder-IF shows a 22% numerical increase in average Spearman correlation (0.26 to 0.32) compared with vanilla ESM-IF and outperforms ESM-IF on five of seven assays; however, the assay-level paired Wilcoxon test does not reach statistical significance (p = 0.188). For seed-averaged top-ranking enrichment, SimBinder-IF has the highest 20-fold improvement@20 mean (0.453), whereas ESM-IF has the highest 10-fold improvement@10 mean (0.520 vs. 0.487 for SimBinder-IF). In a case study redesigning antibody F045-092 to target the A/California/04/2009 pandemic H1N1 (pdmH1N1) strain—a target the original antibody fails to bind—SimBinder-IF generates variants with markedly lower predicted binding free energy than ESM-IF (mean ΔΔG: −68.56 vs. −49.77 kcal/mol). Notably, SimBinder-IF updates only 18% of the ESM-IF parameters. Regarding generic protein–protein affinity modelling, SimBinder-IF shows class-dependent preservation with trade-offs, improving performance on antibody–antigen (AB/AG) and protease–protein inhibitor (Pr/PI) complexes while yielding slightly lower aggregate mean correlations than ESM-IF and ProteinDPO. Availability and Implementation The source code and model weights for SimBinder-IF are available at https://github.com/MSBMI-SAFE/ SimBinder-IF. Supplementary Information The supplementary file contains additional analyses of paratope prediction, statistical confidence, sequence identity, training efficiency, and the ESM-IF architecture.
Reference Key
openalex_W7170761664 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Xinyan Zhao, Yi-Ching Tang, Rivaaj Monsia, Victor Cantu, Ashwin Ramesh, Siyu Yang, Xiaozhong Liu, Zhiqiang An, Xiaoqian Jiang, Yejin Kim
Journal BMC Bioinformatics
Year 2026
DOI
10.1093/bioinformatics/btag548
URL
https://doi.org/10.1093/bioinformatics/btag548
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.